Citation: 2014 BCSECCOM 222
Cease Trade Order
SunVault Energy, Inc.
Vansen Pharma Inc.
(each referred to separately as the Reporting Issuer)
Section 164 of the Securities Act, R.S.B.C. 1996, c. 418
? 1 The Reporting Issuer is an OTC reporting issuer under Multilateral Instrument 51-105
Issuers Quoted in the U.S. Over-the-Counter Markets (MI 51-105).
? 2 The Reporting Issuer has not filed:
1. interim financial statements for the interim period ended March 31, 2014 as required
under Part 4 of National Instrument 51-102 Continuous Disclosure Obligations
(NI 51-102) and section 5(b) of MI 51-105, and
2. a Form 51-102F1 Management's Discussion and Analysis for the period ended
March 31, 2014 as required under Part 5 of NI 51-102 and section 5(b) of MI 51-105
(the required records).
? 3 Under section 164(1) of the Act, the Executive Director orders that all trading in the
securities of the Reporting Issuer cease until:
1. it files the required records, completed in accordance with the Act and rules, and
2. the Executive Director revokes this order as it applies to the Reporting Issuer.
? 4 June 6, 2014
Michael L. Moretto, CA, CPA (Illinois)
Manager
Corporate Finance
Google Übersetzer
